| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 16,924,607 | | Cost of Revenue | 8,963,996 | | | Gross Profit | 7,960,611 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 3,040,456 | | Non Recurring |
-
| | Others |
-
| | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | 4,920,156 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,803,254 | | Earnings Before Interest And Taxes | 6,723,410 | | Interest Expense | 9,688 | | Income Before Tax | 6,713,722 | | Income Tax Expense | 2,289,652 | | Minority Interest | (3,128) | | | | Net Income From Continuing Ops | 4,420,942 | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | 4,420,942 | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | $4,420,942 |
|
1.48% Nasdaq 
Income Statement
